Lung Disease Clinical Trial
Official title:
Randomized Trial Between Buttressed and Non Buttressed Stapling in Pulmonary Lobectomy
Verified date | January 2012 |
Source | Medtronic - MITG |
Contact | n/a |
Is FDA regulated | No |
Health authority | Japan: Institutional Review Board |
Study type | Interventional |
The objective of this study is to confirm superiority between a test treatment group using Endo GIA stapler with Duet Tissue Reinforcement System (TRS) and a current international standard of care group using a conventional stapler in patients undergoing pulmonary lobectomy surgery, using a randomized comparative study of the frequency of intraoperative air leak.
Status | Terminated |
Enrollment | 100 |
Est. completion date | January 2012 |
Est. primary completion date | January 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 20 Years to 79 Years |
Eligibility |
Inclusion Criteria: - The patient is between 20-79 years of age. - The patient is eligible to be given pulmonary Lobectomy. - The patient is scheduled to undergo pulmonary Lobectomy. - Performance status 0~1 (Eastern Cooperative Oncology Group classification). - The patient has no history of lung surgery. - The patient is healthy organ function. - The patient is scheduled for surgery with staplers . - The patient must be willing and able to participate in the study procedures and able to understand and sign the informed consent. Exclusion Criteria: - The patient has suffered thoracic trauma or has previously undergone pneumonectomy surgery. - The patient has an active bacterial infection or fungal infection. - The patient is undergoing continuing systemic administration (intravenous or oral) of steroids. - The patient condition is complicated by uncontrolled diabetes mellitus. - The patient participation is judged difficult due to study complications related to a psychiatric disorder or psychological symptoms. - The patient undergoes surgical procedure other than lobectomy during surgery. - Reinforcement material other than the study materials are applied during surgery. - The patient judged unsuitable for study participation by the investigator for any other reason. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Japan | Junendo University School of Medicine | Tokyo |
Lead Sponsor | Collaborator |
---|---|
Medtronic - MITG |
Japan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Frequency of intraoperative air leak | Occurence of intraoperative air leak will vary from patient to patient and will be recorded for all patients. | Day 0 | Yes |
Secondary | Postoperative duration of air leak | Duration of air leak will vary from patient to patient. Published literature states a duration of greater than 7 days occurs in 15% of patients. | Month 1 (Average time period) | No |
Secondary | Duration of chest drainage | Duration of chest drainage will vary from patient to patient. | Month 1 (Average time period) | No |
Secondary | Frequency of intraoperative sealant use | The need to use a sealant intraoperatively will be assessed for each patient during surgery. | Day 0 | No |
Secondary | Incidence of intraoperative adverse events | The occurence of adverse events during surgery will be recorded for each patient. | Day 0 | No |
Secondary | Incidence of postoperative adverse events | Patients are not required to return to the clinic at a specific time point. Any adverse events that occur after discharge will be captured. | Month 1 (Average time period) | No |
Secondary | Days of hospitalization | Discharge date will vary from patient to patient | Month 1 (Average time period) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02253667 -
Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients
|
N/A | |
Completed |
NCT02217423 -
Abdominal Circumference and Cardiorespiratory Repercussions in Patients Submitted to Physical Therapy
|
N/A | |
Completed |
NCT02345135 -
Susceptibility to Infections in Ataxia Telangiectasia
|
N/A | |
Completed |
NCT01679301 -
Evaluation of Sleep Mode Within the Respironics SimplyGo Portable Oxygen Concentrator
|
N/A | |
Terminated |
NCT00966823 -
Fetal Tracheal Balloon Study in Diaphragmatic Hernia
|
Phase 2 | |
Completed |
NCT00139152 -
Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair
|
Phase 4 | |
Completed |
NCT00052052 -
An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF)
|
Phase 2 | |
Completed |
NCT00013949 -
Cardiovascular Vulnerability to Particulate Exposure
|
N/A | |
Recruiting |
NCT02963467 -
Effect of Smoking on Ventilation-Perfusion Ratio
|
N/A | |
Recruiting |
NCT02965300 -
The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis
|
N/A | |
Enrolling by invitation |
NCT02946658 -
Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders
|
Phase 1/Phase 2 | |
Recruiting |
NCT02913365 -
Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis
|
N/A | |
Completed |
NCT01735526 -
Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide After Hematopoietic Stem-cell Transplantation
|
N/A | |
Completed |
NCT01952002 -
Clinical Safety for the Inspiratory Muscle Training
|
N/A | |
Recruiting |
NCT01450644 -
Evaluation of the Hospital2Home Palliative Care Service for Patients With Advanced Progressive Lung Disease
|
Phase 2 | |
Completed |
NCT01153321 -
Investigation of the Effect of Oral Treatment With 100 mg AZD2423 in Subjects With Mild Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Completed |
NCT01215279 -
AZD2423 Safety and Tolerability Study in Patients With Moderate and Severe Chronic Obstructive Pulmonary Disease(COPD)
|
Phase 2 | |
Completed |
NCT00837681 -
Pulmonary Complications of Hematopoietic Stem Cell Transplantation
|
N/A | |
Completed |
NCT02055222 -
Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease
|
||
Completed |
NCT01222442 -
To Evaluate the Effect of AZD3199 on the Electrical Activity in the Heart
|
Phase 1 |